Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk Factors
NCT06796582
Summary
Exercise training is a cornerstone in the prevention and rehabilitation of cardiovascular disease. While research has primarily focused on endurance training, resistance training becomes more and more important. The gold standard to prescribe resistance training intensity or monitor longitudinal changes is the 1-Repetition-Maximum (1-RM) test. However, particularly for unexperienced individuals, this test may not be recommendable due to the high load and an increased risk of injuries. Alternatively, there are several published formulas to estimate the 1-RM based on a multiple-repetition-maximum (or repetition-to-failure) test. However, these formulas have been primarily tested in healthy individuals. Moreover, the reliability of the 1-RM estimation based on two tests with different submaximal weight is unknown. Therefore, the present study evaluates the agreement of the 1-RM estimation (based on different formulas) between two Multiple-RM tests with different weight in 50 patients with cardiovascular disease (heart failure, coronary heart disease, atrial fibrillation) or cardiovascular risk factors (type 2 diabetes, arterial hypertension).
Eligibility
Inclusion Criteria: * Age ≥ 50 years * At least one of the following cardiovascular diseases / risk factors: * Heart failure * Coronary heart disease * Atrial fibrillation * Arterial hypertension * Type 2 diabetes mellitus * Clinically stable for ≥ 4 weeks * Medical clearance to perform resistance training / strength testing * Signed written informed consent Exclusion Criteria: * Pregnancy * Acute infection * Chronic joint inflammation * Knee, hip, ankle, wrist, elbow or shoulder pain * Known osteoporosis (T-value ≤ -2.5) * Uncontrolled hypertension (≥160 mmHG systolic / ≥100 mmHG diastolic) * Known cerebral or thoracic aneurysm
Conditions7
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06796582